Tag Archives: heath

Tony Coelho: A Patient Advocate’s Perspective on Paying for Value

lab_tech

Yesterday, Health Affairs published an op-ed by Tony Coelho, Former Member of the U.S. House of Representatives and Chairman of the Partnership to improve patient care, on the benefit of patient-centered outcomes research to better inform medical care, without limiting patients’ and providers’ choices. As Coelho writes, ‘The movement to place greater financial risk on providers in an effort to pay for value rather than volume will have the effect of fundamentally changing the way Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Tekmira Pharmaceuticals Ebola Drug Gets Nod From FDA

BIO Investor Forum

The U.S. Food and Drug Administration has authorized Canada’s Tekmira Pharmaceuticals to provide an experimental drug to people with confirmed or suspected Ebola virus infections, according to an article in The Wall Street Journal. “Our TKM-Ebola drug supplies are limited, but we will continue to help where we can,” Tekmira Chief Executive Mark J. Murray said in a press release. The drug is still in clinical testing to assess whether it is safe and effective. BIO Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Differences Between Establishing Value for Approval Versus Coverage?

shutterstock_26191726

Yes, but maybe not irreconcilable. Many of the educational sessions on the first day of the 2014 BIO International Convention touched on one essential question: how can safe and effective treatments get to the patients who need them faster? Panelists in the session Irreconcilable Differences? A Balanced Approach to Establishing Value approached this key question through a discussion of how to shorten the time between—and improve the predictability and expectations around—regulatory approval and coverage and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,